• Menu
  • About Melanoma
    • Melanoma 101
    • Melanoma & Skin of Color
    • Types of Melanoma
      • Cutaneous Melanoma
      • Acral Melanoma
      • Uveal Melanoma
      • Mucosal Melanoma
      • Other Types of Skin Cancer
    • Melanoma Staging
      • Stage 0
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
      • Breslow Depth and Clark Level
      • Understanding Melanoma Staging
      • Melanoma Survival Rates
    • Statistics
    • Prevention
      • Sunscreen
      • Protective Clothing
      • UV Index
      • Infographics
    • Early Detection
      • What to Look For
      • Monthly Self Exam
      • Full-Body Skin Exam
      • Skin Check Pledge
    • Stories
      • Facing Melanoma Together
      • Patient & Survivor Stories
      • Family & Caregiver Stories
  • For Patients
    • Just Diagnosed
      • Getting Educated About Melanoma
      • Choosing Your Doctor
      • Assembling Your Family & Friends
      • Understanding Your Health Insurance
      • Keeping Your Medical Records Organized
      • Getting a Second Opinion
      • Considering Clinical Trials
      • Connecting with the Melanoma Community
      • Communicating with your Doctor
      • Practicing Self Care
    • Melanoma Treatment
      • Immunotherapy
      • Targeted Therapy
      • Combination Therapy
      • Adjuvant Therapy
      • Therapies in Development
    • Clinical Trials
      • About Clinical Trials
      • Participation and Expectations
      • Benefits and Risks
      • Patient Success Stories
      • Find a Clinical Trial
      • FAQ
      • Questions to Ask
      • Myths Debunked
      • Fight Back Give Back
    • Patient Resources
      • Melanoma > Exchange
      • Glossary of Melanoma Terms
  • Research
    • Research Overview
    • MRA Grant Awards
    • Request for Proposals
      • MRA General RFP
      • MRA/ACS Special Opportunity
      • Dermatology Fellows Award
    • Scientific Retreat
      • 2021 Retreat
      • Future MRA Retreats
      • Previous MRA Retreats
    • Antidote Bridge
    • MRA Grant Mechanisms
  • Get Involved
    • Donate
    • Blog
    • Sign Up for Emails
    • Events
      • Leveraged Finance Fights Melanoma
      • Melanoma Exchange Patient Forum
    • Fundraise for MRA
      • Online Fundraising Opportunities
      • Host an Event
    • Honor a Loved One
      • Memorial Tribute Information
    • Sponsor a Named Award
    • Corporate Partnerships
    • Workplace Giving
  • About MRA
    • MRA Overview
    • Board of Directors
      • Debra Black
      • Leon Black
      • Ben Black
      • Margaret Anderson
      • Maria Bell
      • Ellen Davis
      • Amanda Eilian
      • Jason Daniel Federici
      • Jami Gertz
      • Daisy Helman
      • Susan Hess
      • Denise Kellen
      • Michael Klowden
      • Nancy Marks
      • Michael Milken
      • Richard Ressler
      • Mary Jo Rogers
      • Jeffrey Rowbottom
      • Ian Schuman
      • Elliott Sigal, M.D., Ph.D.
      • Jonathan W. Simons, M.D.
      • Jonathan Sokoloff
      • Elizabeth Stanton
      • Suzanne L. Topalian, M.D.
    • Staff
      • Michael Kaplan
      • Marc Hurlbert
      • Kristen Mueller
      • Joan Levy
      • Cody Barnett
      • Carolyn Ricci
      • Janine Rauscher
      • Tyler Brown
      • Rachel Fischer
      • Renee Orcione
    • Scientific Advisory Panel
    • Grant Review Committee
    • Medical Advisory Panel
    • Dermatology Council
    • MRA Press Releases
    • Financials
    • Careers
    • Corporate Allies
    • Annual Reports

       
DONATE
  • UV Exposure & Risk of Cutaneous Melanoma in Skin of Color

    In JAMA Dermatology, a team led by Adewole S. Adamson, MD, from The University of Texas at Austin, investigates whether there is an association, specifically in People of Color, between UV exposure and melanoma. MRA breaks down the research findings and evaluates how it should impact your sun safety practices.

    Read More
  • A Melanoma Miracle Paid Forward

    When Lauren was living in Tanzania, she made a bucket list that included 'seeing a miracle." Little did she know she would become her own melanoma miracle. Almost eight years later, she is just beginning her career as a nurse and continues to be NED.

    Read More
  • Relentless in the Fight: Dr. F. Stephen Hodi

    Every revolution needs trailblazers—people who restlessly and relentlessly search for paths forward. At MRA, we’re fortunate to partner with innovative trailblazers who are guiding the entire field of melanoma further, such as two time MRA-funded investigator Dr. F. Stephen Hodi.

    Read More
  • Craig Finds Meaning in His Melanoma Diagnosis in the COVID-19 Era

    “I believe there is a reason that I’m going through this. If I can help prevent someone else’s melanoma, or make their journey easier, or help advance research – that’d be worth it,” says Craig. “I feel honored to be part of the melanoma community. It’s a powerful community – and I feel obligated to do something in support of it.”

    Read More
  • Find a Clinical Trial

    Melanoma Clinical Trial Finder
  • Get Connected

    Find Support for melanoma
  • Scientific Report

    Retreat Report Box 2020
  • Get Involved

    Get Involved with Melanoma Outreach
  • About MRA

    Melanoma video

What's New

04/14/2021 – UV Exposure & Risk of Cutaneous Melanoma in Skin of Color

03/26/2021 – A Melanoma Miracle Paid Forward

03/24/2021 – Dr. James Allison on the Path to More Effective Immunotherapies

03/11/2021 – Craig Finds Meaning in His Melanoma Diagnosis in the COVID-19 Era

03/05/2021 – Relentless in the Fight: Dr. F. Stephen Hodi

Login

I've lost my password

×

MRA would like to thank our 2021 Scientific Retreat Sponsors

  • Presenting Sponsors

    • Bristol-Myers Squibb
    • Merck
  • Platinum Sponsor

    Amgen Oncology
  • Gold Sponsors

    • Alkermes
    • Iovance
    • Johnson & Johnson
    • Pfizer
    • NEKTAR
    • Novartis

Melanoma Research Alliance

730 15th Street, NW
Washington, DC 20005
(202) 336-8935

info@curemelanoma.org
#14131

About MRA

As the largest non-profit funder of melanoma research, MRA has dedicated $123 million to date in support of the fight against melanoma.

Privacy Statement